Biocept, Inc.

The momentum for this stock is not very good. Biocept, Inc. is not very popular among insiders. Tradey thinks it is not wise to invest in Biocept, Inc..

Biocept, Inc. is an oncology laboratory service company, which focuses on the development and market...

News

Biocept filed voluntary petition for Chapter 7 bankruptcy relief

The Fly See the rest of the story here.\n\nthefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...\n more…

Biocept (NASDAQ:BIOC) Rating Increased to Hold at StockNews.com

Ticker Report StockNews.com upgraded shares of Biocept (NASDAQ:BIOC Free Report) from a sell rating to a hold rating in a research note published on Thursday. Biocept Stock Up 1.9 % Shares of NASDAQ:BIOC...\n more…

Biocept, Inc. (NASDAQ:BIOC) Short Interest Update

Zolmax Biocept, Inc. (NASDAQ:BIOC Get Free Report) saw a large increase in short interest in the month of September. As of September 15th, there was short interest totalling 610,600 shares, an...\n more…

Biocept announces full enrollment in FORESEE trial

Enrollment Completed in the Feasibility Phase of the FORESEE Clinical Trial with Biocepts CNSide Assay to Evaluate Patients with Leptomeningeal Metastases

Business Wire Biocept, Inc. (Nasdaq: BIOC), a leading provider of molecular diagnostic assays, products and services, announces the full enrollment of 40 subjects with breast or non-small cell lung cancer (NSCLC...\n more…

Why Is Cancer Diagnostic Focused Biocept Stock Trading Higher Today?

Yahoo! Finance: News Why Is Cancer Diagnostic Focused Biocept Stock Trading Higher Today...\n more…